2 results match your criteria: "4 New York Center for Voice and Swallowing Disorders[Affiliation]"
Ann Otol Rhinol Laryngol
February 2018
3 Department of Otolaryngology-Head and Neck Surgery, Mount Sinai Roosevelt Hospital, New York, New York, USA.
Objective: The aim was to study the feasibility of performing office-based laryngeal procedures employing a flexible hollow steerable sheath placed contralateral to the nostril through which a standard flexible video endoscope is placed.
Methods: The study design included simulation of transnasal endoscopic laryngeal procedures evaluating the use of a flexible steering sheath in laboratory and clinic settings. Transnasal laryngeal procedures were performed in an otolaryngology office setting employing an airway-management-trainer mannequin and then repeated in a human cadaver lab with standard transnasal flexible video laryngoscopy.
Ann Otol Rhinol Laryngol
April 2017
4 New York Center for Voice and Swallowing Disorders, New York, New York, USA.
Objective: Metformin is an oral anti-hyperglycemic agent used to treat type 2 diabetes mellitus (DM). In vitro and animal models have shown that metformin can prevent the progression of oral lesions to carcinoma; however, there is conflicting data in the clinical literature regarding risk reduction for malignancy in head and neck cancer (HNC).
Study Design: Case series.